cytogenetics
Bionano Genomics Receives Nasdaq Warning Over Low Share Price
The San Diego-based genome mapping firm's share price fell below $1.00 for 30 consecutive days, triggering a noncompliance notification from Nasdaq.
Oppenheimer Initiates Coverage of Bionano Genomics at Outperform
The investment bank said the company's molecular diagnostics have the potential to replace microarrays for cytogenetics analysis.
Impact Lab Group Acquires Toma Advanced Biomedical Assays Services Lab
The acquisition will allow the firms to provide annotated biospecimens, as well as sequencing, bioinformatics, and lab services to hospitals and clinicians.
Through the new lab, NeoGenomics can work with pharmaceutical clients through the different phases of drug development, including the development of companion diagnostics.
Poplar Healthcare Acquires Genetics of Memphis
As part of the deal, Genetics' cytogenetics training facility — one of five accredited cytogenetics training facilities in the US — will be transferred to Poplar.